Effect of Low-Concentration Atropine Eye Drops on Parapapillary Gamma Zone Development and Enlargement over 3 Years: The LAMP Study.
Purpose To evaluate the longitudinal changes in the parapapillary gamma zone in children receiving 0.05%, 0.025%, or 0.01% atropine eye drops and placebo/switchover over 3 years based on the Low-Concentration Atropine for Myopia Progression (LAMP) study. Design A secondary analysis from a randomized controlled trial. Participants Two hundred eighty children underwent spectral-domain OCT at baseline, which involved 24 equally spaced radial OCT B-scans of the optic nerve head, taken at 1-year...